#PharmaNews #GLP1 #ObesityTreatment #EliLilly #NovoNordisk #HealthcareTrends #PharmaIndustry To view or add a comment, sign in Nereus Expands Potential Use in GLP-1 Patients Vanda Pharmaceuticals has initiated a Phase 3 trial evaluating Nereus (tradipitant) to prevent nausea and vomiting in patients receiving high-dose GLP-1 therapies
NSDR, Naps 00:33:34 Recap & Key Takeaways 00:36:38 Zero-Cost Support, YouTube, Spotify & Apple Follow & Reviews, Recommendations, Sponsors Disclaimer & Disclosures Day 229 Dr
Its not about instant fixes but real, visible improvements with consistent use
They work by mimicking the effects of a hormone called GLP-1, which helps regulate blood sugar levels and control appetite
For testing on a first-time melanotan II subject, it is important to start with the lowest dose possible, before increasing as needed to achieve the desired outcome